Akebia Therapeutics
AKBA
#6350
Rank
A$0.97 B
Marketcap
$3.72
Share price
4.39%
Change (1 day)
76.47%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2024 (TTM): -A$0.11 Billion

According to Akebia Therapeutics's latest financial reports the company's current earnings are A$0.16 Billion. a decrease over its 2023 earnings that were of -A$81.19 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.11 Billion33.68%
2023 -A$81.19 Million-45.12%
2022 -A$0.15 Billion-66.55%
2021 -A$0.45 Billion-26.24%
2020 -A$0.6 Billion33.94%
2019 -A$0.45 Billion66.52%
2018 -A$0.27 Billion123.53%
2017 -A$0.13 Billion-43.34%
2016 -A$0.22 Billion123.58%
2015 -A$94.94 Million63.95%
2014 -A$57.91 Million181.24%
2013 -A$20.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.20 B-6,740.25%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.32 B-19,751.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$27.27 B-25,228.94%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.19 Billion 71.73%๐Ÿ‡บ๐Ÿ‡ธ USA